2m 2m 2m 2m 2m 2m 2m
RENOVORX (RNXT)
NASDAQ
$0.93+$0.02 (+2.58%)
Price as of Jun 03, 2026 7:16 PM EDT- $41.0MMarket Cap
- -33.54%1-Year Change
- BiotechnologyIndustry
RENOVORX (RNXT)
$0.93+$0.02 (+2.58%)
RNXT | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $0.91 | ||
Change | -$0.01 (-1.11%) | ||
Open | $0.95 | ||
High | $0.97 | ||
Low | $0.91 | ||
Previous Close | $0.92 | ||
Volume | 244,381 | ||
30-Day Average Volume | 310,243 | ||
1-Week Change | -0.58% | ||
1-Month Change | 3.08% | ||
1-Year Change | -33.54% | ||
3-Year Change | -56.23% | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 45.1M | ||
Total Assets | $14.0M | ||
Market Cap | $41.0M | ||
Enterprise Value | $28.7M | ||
Period: QTR TTM FY | |||
Revenue | $563,000.00 | ||
Net Income | -$3.5M | ||
Free Cash Flow | -$3.7M | ||
EBIT | -$3.5M | ||
EBITDA | -$3.5M | ||
Net Working Capital | $11.8M | ||
EPS | -$0.09 | ||
Enterprise Value/EBITDA | -8 | ||
Enterprise Value/Revenue | 51 | ||
P/B | 4 | ||
P/E | -10 | ||
PEG | N/A | ||
Price/Free Cash Flow | -11 | ||
Price/Operating Cash Flow | -11 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue